Bristol-Myers Squibb to Take Part at the Wolfe Research Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends up on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Bristol-Myers Squibb (BMY) Tops Q3 EPS by 10c, Updattes FY Guidance
October 31, 2019 7:02 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $1.17, $0.10 better than the analyst estimate of $1.07. Revenue for the quarter came in at $6.01 billion versus the consensus estimate of $5.89 billion.
GUIDANCE:
Bristol-Myers Squibb sees Q4 2019 EPS of $4.25-$4.35, versus the consensus of... More
